Issue: August, 2021

Read more

July 10, 2021
1 min read
Save

Thoracic oncologist named Winship Cancer Institute executive director

Issue: August, 2021
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Suresh S. Ramalingam, MD, has been appointed executive director of Winship Cancer Institute of Emory University.

Ramalingam, a thoracic oncologist, served as the institute’s deputy director since 2016.

In his new role, he will continue to lead efforts to extend local access to cancer research and care at Emory Healthcare’s six hospitals in the Atlanta area.

He will lead Winship’s effort to seek renewal of its NCI designation. He also will help oversee the construction and opening of a new 17-story cancer facility on the campus of Emory University Hospital Midtown.

“Dr. Ramalingam is the ideal person to lead Winship into the future of cancer research and care,” Jonathan S. Lewin, MD, executive vice president for health affairs at Emory, as well as chairman of the board Emory Healthcare, said in a press release. “He has been instrumental to our success in seamlessly blending Winship’s three missions: research, clinical and education. His collaborative experience and skills will be critical as we enter new frontiers in the world of cancer that will revolutionize the way we treat those who are diagnosed with this deadly disease.”

Ramalingam’s research has focused on development of individualized therapies for non-small cell lung cancer.

He will continue to serve as assistant dean for cancer research at Emory University School of Medicine, where he is professor of hematology and medical oncology, director of the division of medical oncology, and Roberto C. Goizueta distinguished chair for cancer research.

Suresh S. Ramalingam, MD
Suresh S. Ramalingam

“I am deeply honored by the trust placed in me to lead Winship,” Ramalingam said in the release. “With its exceptional researchers, physicians, nurses and staff, Winship is well-positioned to make seminal contributions to improving the lives of [patients with cancer]. ... Together, we will continue to build Winship’s eminence as a destination cancer center, and we will remain steadfast in our dedication to accelerating cures and inspiring hope.”

Ramalingam joined Winship in 2007. He previously served as assistant professor at University of Pittsburgh School of Medicine and Wayne State University.